Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne

Clinical trial NCT05704114 · COMPLETED

Trial details

NCT number: NCT05704114
Sponsor: Dr. Emmy Graber
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acne Vulgaris Post Inflammatory Hyperpigmentation Post Inflammatory Pigmentation Change Erythema Skin Scarring

Start date: 2021-02-01
Primary completion: 2022-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.